Millipore Sigma Vibrant Logo

05-831-I Anti-Amyloid Beta (ABeta) x-42 Antibody, clone 12F4

Anti-Amyloid Beta (ABeta) x-42, clone 12F4 is an antibody targeting the Amyloid Beta (ABeta) x-42 protein, validated for use in IHC & ELISA.

FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.
Research Category: Neuroscience Research Sub-Category: Neurodegenerative Diseases Gene Symbol: APP, A4, AD1 UniProt Number: P05067
View Products on Sigmaaldrich.com
05-831-I
100 µL  
Prix en cours de récupération
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
Maximum Quantity is
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
—
Demander le prix
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      Offres spéciales

       

      Contacter le Service Clients

      Aperçu

      Replacement Information

      Offres spéciales

      100% Performance Guaranteed

      Tableau de caractéristiques principal

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      HIHC, ELISAMPurifiedMonoclonal Antibody
      Description
      Catalogue Number05-831-I
      Replaces05-831
      DescriptionAnti-Amyloid Beta (ABeta) x-42 Antibody, clone 12F4
      Alternate Names
      • Amyloid beta A4 protein
      • ABPP
      • APPI
      • APP
      • Alzheimer disease amyloid protein
      • Cerebral vascular amyloid peptide
      • CVAP
      • PreA4
      • Protease nexin-II
      • PN-II
      Background InformationOne of the most important and initial steps which causes loss of memory and cognition in Alzheimer’s Disease (AD) involves proteolytic cleavage of amyloid precursor protein (APP, chromosome 21) releasing short 40, 42 & 43 amino acid peptides (Amyloid Beta) 1-40, 1-42 and 1-43). Polymerization of beta-amyloid and subsequent neuronal deposit (amyloid) leads to the degeneration of neurons involved in memory and cognition.
      References
      Product Information
      FormatPurified
      Control
      • Human Alzheimer's brain tissue.
      PresentationPurified mouse monoclonal IgG1κ in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
      Quality LevelMQ100
      Applications
      ApplicationAnti-Amyloid Beta (ABeta) x-42, clone 12F4 is an antibody targeting the Amyloid Beta (ABeta) x-42 protein, validated for use in IHC & ELISA.
      Key Applications
      • Immunohistochemistry
      • Enzyme Immunoassay (ELISA)
      Application NotesImmunohistohemistry Analysis: A 1:500 dilution from a representative lot detected Amyloid Beta (ABeta) x-42 in human pons/midbrain tissue.

      ELISA Analysis: A representative lot detected Amyloid Beta (ABeta) x-42, but demonstrates a loss of signal against Amyloid Beta (ABeta) x-42.

      Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected Amyloid Beta (ABeta) x-42, but demonstrated a loss of signal against x-40 and not x-43 in WB (Prof. J. Buxbaum, Mt. Sinai School of Medicine).
      Biological Information
      ImmunogenKLH-conjugated linear peptide corresponding to human Amyloid Beta (ABeta) x-42.
      Clone12F4
      ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
      HostMouse
      SpecificityThis antibody detects Amyloid Beta (ABeta) x-42, but does not cross react with Amyloid Beta (ABeta) x-40 or Amyloid Beta (Abeta) x-43.
      IsotypeIgG1κ
      Species Reactivity
      • Human
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Gene Symbol
      • APP
      • A4
      • AD1
      Purification MethodProtein G Purified
      UniProt Number
      Molecular Weight4 kDa calculated
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Immunohistochemistry in human Alzheimer's disease brain tissue.

      Immunohistochemistry Analysis: A 1:2,000 dilution of this antibody detected Amyloid Beta (Abeta) x-42 in human Alzheimer's disease brain tissue.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
      Packaging Information
      Material Size100 µL
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      05-831-I 04053252854774

      Documentation

      Anti-Amyloid Beta (ABeta) x-42 Antibody, clone 12F4 FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      Anti-Amyloid Beta (ABeta) x-42 Antibody, clone 12F4 Certificats d'analyse

      TitreNuméro de lot
      Anti-Amyloid Beta (ABeta) x-42, clone 12F4 - Q2129762 Q2129762
      Anti-Amyloid Beta (ABeta) x-42, -2520499 2520499
      Anti-Amyloid Beta (ABeta) x-42, -2547766 2547766
      Anti-Amyloid Beta (ABeta) x-42, -2548731 2548731
      Anti-Amyloid Beta (ABeta) x-42, -2567139 2567139
      Anti-Amyloid Beta (ABeta) x-42, -2583433 2583433
      Anti-Amyloid Beta (ABeta) x-42, -2616196 2616196
      Anti-Amyloid Beta (ABeta) x-42, -2651999 2651999
      Anti-Amyloid Beta (ABeta) x-42, -2768480 2768480
      Anti-Amyloid Beta (ABeta) x-42, clone 12F4 - 3071653 3071653
      Show more

      Newsletters / Publications

      Title
      Research Focus - Volume 2, 2013